---
# Display name
title: |
  Bin Xu
  许膑

# Full name (for SEO)
first_name: Bin
last_name: Xu

# Username (this should match the folder name)
authors:
  - 许膑

# Is this the primary user of the site?
superuser: false

# Role/position
role: 23 PhD Student in Biomedical Engineering

# Organizations/Affiliations
organizations:
  - name: South China University of Technology
    url: 'https://www.scut.edu.cn/new/'

# Short bio (displayed in user profile at end of posts)
bio: My research interests include cancer treatment, drug delivery, machine learning, biomarkers, material development.

interests:
  - Cancer Treatment
  - Machine Learning
  - Biomarkers
  - Material Development

education:
  courses:
    - course: PhD in Biomedical Engineering
      institution: South China University of Technology
      year: Currently Enrolled (2023 - Present)
    - course: MM in Surgery
      institution: Southern Medical University
      year: 2022
    - course: MBBS in Clinical Medicine
      institution: Southern Medical University
      year: 2019

# Social/Academic Networking
# For available icons, see: https://docs.hugoblox.com/getting-started/page-builder/#icons
#   For an email link, use "fas" icon pack, "envelope" icon, and a link in the
#   form "mailto:your-email@example.com" or "#contact" for contact widget.
social:
  - icon: envelope
    icon_pack: fas
    link: 'mailto:bun_hui@126.com'
# Link to a PDF of your resume/CV from the About widget.
# To enable, copy your resume/CV to `static/files/cv.pdf` and uncomment the lines below.
# - icon: cv
#   icon_pack: ai
#   link: files/cv.pdf

# Enter email to display Gravatar (if Gravatar enabled in Config)
email: ''

# Organizational groups that you belong to (for People widget)
#   Set this to `[]` or comment out if you are not using People widget.
user_groups:
  - Graduate Students
---

Bin obtained his Master of Medicine degree from Southern Medical University in 2022 and shortly thereafter joined the Shidang Team. His research focuses on the development and application of integrated diagnosis and treatment biomaterials in tumor targeting and immune therapy drug delivery. Currently, he is committed to applying artificial intelligence to early tumor diagnosis, designing and developing drug delivery carriers, and enhancing precise prediction of drug efficacy.
